Société de Therapeutique Marocaine S.A.

CBSE:SOT Stock Report

Market Cap: د.م6.8b

Société de Therapeutique Marocaine Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Lamia Tazi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure23.6yrs
CEO ownershipn/a
Management average tenure5.9yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

CEO

Lamia Tazi

23.6yrs

Tenure

Dr. Lamia Tazi serves as Chairman and Chief Executive Officer at Societe de Therapeutique Marocaine S.A. and its Director since May 17, 2001. Dr. Tazi served as the Managing Director of Pharmacy at Societe...

Leadership Team

NamePositionTenureCompensationOwnership
Lamia Tazi
Chairman & CEOno datano datano data
Adnane Hilal
Administrative & Financial Directorno datano datano data
Mehdi Zaghloul
Executive Director of Operations7.9yrsno datano data
Mourad Benhammacht
Director of Human Capitalno datano datano data
Rachida Khalifa
Sales Directorno datano datano data
Ouadie El Euldj
Marketing Directorno datano datano data
Mohamed Tazi
Executive Support Director & Executive Director5.9yrsno datano data
Khaneboubi Ghizlaine
Industrial Executive Director & Development4.9yrsno datano data
Najlaa El Hany
Director of Business Development & Oncology Divisionno datano datano data
Ahmed Chaouki Berrannoun
Director of Support Divisionno datano datano data
Moulay Hachem Alaoui
Director of the International Operationsno datano datano data
Mehdi Berrada
Director of Productionno datano datano data

5.9yrs

Average Tenure

Experienced Management: SOT's management team is seasoned and experienced (5.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lamia Tazi
Chairman & CEO23.6yrsno datano data
Mohamed Tazi
Executive Support Director & Executive Director7.6yrsno datano data
Mohamed Benhalima
Independent Director5yrsno datano data
Mohammed Berrada
Non-Executive Director24.6yrsno datano data
Mohamed Sefrioui
Non-Executive Director29.5yrsno datano data
Berrada Amine
Non-Executive Director11.5yrsno datano data
Selma Tazi
Non-Executive Director6.6yrsno datano data
Amal Diouri
Non-Executive Director9.5yrsno datano data
El Ghaly Joutei
Non-Executive Director13.6yrsno datano data
Ali Tazi
Non-Executive Director6.6yrsno datano data
Bahia Berrada
Non-Executive Director4.5yrsno datano data
Noureddine Boutayeb
Independent Director2.6yrsno datano data

8.5yrs

Average Tenure

Experienced Board: SOT's board of directors are considered experienced (8.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:57
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Société de Therapeutique Marocaine S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hicham SaadaniBmce Capital Bourse
null nullUpline Securities